Enzychem Lifesciences Statistics

Total Valuation

Enzychem Lifesciences has a market cap or net worth of KRW 102.99 billion. The enterprise value is -7.62 billion.

Market Cap	102.99B
Enterprise Value	-7.62B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Enzychem Lifesciences has 79.84 million shares outstanding. The number of shares has decreased by -33.09% in one year.

Current Share Class	n/a
Shares Outstanding	79.84M
Shares Change (YoY)	-33.09%
Shares Change (QoQ)	-3.92%
Owned by Insiders (%)	5.19%
Owned by Institutions (%)	5.98%
Float	68.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.31
PB Ratio	0.58
P/TBV Ratio	0.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.97
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1.95

Financial Position

The company has a current ratio of 17.77, with a Debt / Equity ratio of 0.03.

Current Ratio	17.77
Quick Ratio	14.27
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-1.16
Interest Coverage	-47.92

Financial Efficiency

Return on equity (ROE) is -4.16% and return on invested capital (ROIC) is -3.92%.

Return on Equity (ROE)	-4.16%
Return on Assets (ROA)	-3.71%
Return on Capital (ROIC)	-3.92%
Revenue Per Employee	672.72M
Profits Per Employee	-64.41M
Employee Count	122
Asset Turnover	0.40
Inventory Turnover	5.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-28.85%
50-Day Moving Average	1,344.40
200-Day Moving Average	1,657.98
Relative Strength Index (RSI)	49.03
Average Volume (20 Days)	175,920

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enzychem Lifesciences had revenue of KRW 82.07 billion and -7.86 billion in losses. Loss per share was -94.96.

Revenue	82.07B
Gross Profit	5.17B
Operating Income	-12.05B
Pretax Income	-8.27B
Net Income	-7.86B
EBITDA	-8.62B
EBIT	-12.05B
Loss Per Share	-94.96

Full Income Statement

Balance Sheet

The company has 116.29 billion in cash and 4.54 billion in debt, giving a net cash position of 111.75 billion or 1,399.73 per share.

Cash & Cash Equivalents	116.29B
Total Debt	4.54B
Net Cash	111.75B
Net Cash Per Share	1,399.73
Equity (Book Value)	178.68B
Book Value Per Share	2,223.71
Working Capital	147.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.24 billion and capital expenditures -672.21 million, giving a free cash flow of -3.92 billion.

Operating Cash Flow	-3.24B
Capital Expenditures	-672.21M
Free Cash Flow	-3.92B
FCF Per Share	-49.04

Full Cash Flow Statement

Margins

Gross margin is 6.30%, with operating and profit margins of -14.68% and -9.57%.

Gross Margin	6.30%
Operating Margin	-14.68%
Pretax Margin	-10.08%
Profit Margin	-9.57%
EBITDA Margin	-10.50%
EBIT Margin	-14.68%
FCF Margin	n/a

Dividends & Yields

Enzychem Lifesciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	33.09%
Shareholder Yield	33.09%
Earnings Yield	-7.36%
FCF Yield	-3.80%

Stock Splits

The last stock split was on August 17, 2022. It was a forward split with a ratio of 6.

Last Split Date	Aug 17, 2022
Split Type	Forward
Split Ratio	6

Scores

Enzychem Lifesciences has an Altman Z-Score of 9.44.

Altman Z-Score	9.44
Piotroski F-Score	n/a